ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006

NCI Contract Awards.

February 18, 2000

Bush Proposes 16 Percent Increase For NIH, To Complete Budget Doubling.

February 1, 2002

Society Support Program for Training Cytotechnologists

November 29, 1991

September issue of Business & Regulatory Report included (8-page issue).

October 4, 2002

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996